FutureMind Congress: Psychiatry, Psychosomatic Medicine & Mental Health Innovation 2027

Theme : “Integrating Mind, Brain & Technology for Next-Generation Mental Healthcare”

Dubai, UAE | March 17, 2027

Welcome Message

Porf. Zhenhuan LIU

Professor of Pediatric neurologist Nanhai Affiliated Hospital for Women and Children Guangzhou University Chinese Medicine China

Dear Attendees, Presenters, Organizing Committee and Distinguished Guests,

The invitation to write a welcome message and to present at this conference Psychiatry, Psychosomatic Medicine & Mental Health Innovation 2027 is an honor. I am very grateful to the Organizing Committee for emphasizing the important research into neurology and neurological disorders. The conference will enhance the global collective knowledge pertaining to neurological disorders and psychopathologies. The presentations and discussion will also provide crucially important hypotheses and suggestions for new research directions. My own special interest is in neuroimaging by evaluation nerverenovate and neuroplasticity of acupuncture in children with cerebral palsy. I wish you all the very best with your presentations. I only wish I could be there in person especially given its wonderful location!

About FutureMind 2027

FutureMind 2027 is a premier global forum where science, clinical care, and innovation converge to reshape mental health. In London over two days, leaders from around the world in psychiatry, psychosomatic research, neuroscience, and digital health will come together to share new knowledge, debate paradigms, and launch scalable solutions.

This congress is not just about academic exchange — it’s about turning ideas into impact. With keynotes, symposia, workshops, case sessions, and tech showcases, we aim to close the gap between research and real-world use. FutureMind is built to be actionable, inclusive, and future-oriented — a place where attendees don’t just listen but leave ready to transform care delivery

Why Attend?

Attending FutureMind 2027 offers benefits far beyond a typical conference. Here’s what sets it apart:

Hear the latest findings on neuromodulation, psychosomatic pathways, digital diagnostics, and integrated care

Advance your knowledge:

Experience demos of cutting-edge tools — from AI-based decision support to VR therapies and wearables

See innovation live:

Build relationships with global faculty, innovators, policymakers, and collaborators

Network with purpose:

Present your research or project to international peers and compete for recognition through awards

Raise your profile:

Gain strategies to influence policy, scale care models, and integrate new tools into real systems

Drive systemic change:

Walk away with frameworks, checklists, and next steps you can deploy in your organization or research

Leave with action:

One Days Agenda Program

FutureMind 2027

March 17, 2027 | Dubai, UAE

Clinical Advances & Translational Psychiatry

08:30 AM – 09:00 AM

Registration & Welcome Coffee

09:00 AM – 09:20 AM

Opening Ceremony & Welcome Remarks

09:20 AM – 10:00 AM

Keynote 1: Frontiers in Psychiatry and Brain Health Innovation

10:00 AM – 11:15 AM

Plenary: Clinical Advances in Psychopharmacology

Long-acting injectables & depot formulations
Precision dosing & pharmacogenomics
Novel mechanisms & adjunctive strategies
Managing safety, side effects & metabolic risks
Tapering, withdrawal & long-term maintenance care

11:15 AM – 11:30 AM

Coffee Break & Networking

11:30 AM – 12:45 PM

Parallel Scientific Sessions

Track 1: Long-acting Injectables & Adherence
Track 2: Precision Dosing & Biomarker-based Care
Track 3: Adjunctive & Augmentation Strategies

12:45 PM – 13:45 PM

Networking Lunch

13:45 PM – 15:00 PM

Parallel Scientific Sessions

Track 4: Novel Mechanisms in Psychopharmacology
Track 5: Safety, Side Effects & Monitoring
Track 6: Guidelines for Tapering & Maintenance Care

15:00 PM – 15:30 PM

Coffee Break

15:30 PM – 16:30 PM

Panel Discussion: Translational Psychiatry – From Lab to Clinic

Neuroimaging & functional brain mapping
Immune system & neuroinflammation research
Genetics, epigenetics & molecular psychiatry

16:30 PM – 17:00 PM

Poster & Networking Session

17:00 PM – 17:30 PM

Closing Plenary Day 1: Personalised Psychiatry & Future Care Models

Note: Exact speakers, rooms and chairpersons will be assigned in the final program.

Who Should Attend?

FutureMind is tailored to a wide, cross-disciplinary audience. It’s ideal for:

Psychiatrists, psychosomatic medicine specialists, psychologists, neurologists

Mental health nurses, social workers, and allied care providers

Health policymakers, system administrators, global health NGOs

Clinical researchers, neuroscientists, and implementation scientists

Innovation leaders in pharma, biotech, digital health, and medtech

Students, trainees, and early-career investigators who wish to grow and connect

Sessions & Tracks

FutureMind 2027 is structured into major tracks and sub-tracks, each highlighting a specific dimension of psychiatry, psychosomatic medicine, and mental health innovation. Below are the tracks and their sub-tracks with short descriptions:

Clinical Advances in Psychopharmacology

Long-acting injectables and depot formulations:

Exploring innovations in sustained-release medications that improve adherence and reduce relapse

Adjunctive and augmentation strategies:

Combination approaches to enhance outcomes in treatment-resistant disorders

Precision dosing and pharmacogenomics:

How genetic insights and biomarkers personalize treatment and minimize adverse effects

Managing safety, side effects, and metabolic risk:

Best practices in monitoring and mitigating adverse drug effects

Novel mechanisms in psychopharmacology:

New targets such as glutamatergic pathways, immune modulators, and neuropeptides in development

Tapering, withdrawal, and long-term maintenance care:

Guidelines for discontinuation and ensuring sustainable recovery

Session&Track

Neuroscience & Translational Psychiatry

Neuroimaging and functional brain mapping:

Advanced imaging techniques to uncover neural pathways in psychiatric illness.

Circuit-level and connectivity models of illness:

Understanding brain networks and their role in symptoms and treatment response.

Immune system and neuroinflammation research:

The role of inflammation and immune responses in mental disorders.

Animal models bridging laboratory to clinical insights:

Preclinical models that inform human psychiatric research.

Genetics, epigenetics, and molecular psychiatry:

Latest discoveries linking genetic and epigenetic mechanisms to mental health.

Biomarkers for diagnosis and treatment prediction:

Identifying measurable indicators for early detection and personalized care.

Psychosomatic & Brain–Body Integration

Autonomic nervous system and stress regulation:

Examining how stress responses influence physical and mental health.

Inflammation and psychiatric comorbidity:

How systemic inflammation contributes to mood and psychosomatic disorders.

Gut–brain axis, microbiome, and psychobiotics:

Emerging evidence on microbiota and its role in mood and cognition.

Psychoneuroendocrine mechanisms:

The interplay of hormones, stress, and mental health outcomes.

Functional somatic and medically unexplained syndromes:

Approaches to conditions with overlapping physical and psychiatric features.

Integrative and lifestyle-based interventions:

Holistic strategies including nutrition, exercise, and mind-body practices.

Digital Mental Health & AI Tools

Telepsychiatry and hybrid models of care:

Expanding access through remote consultations and blended approaches.

VR/AR applications in therapy and training:

Immersive technologies for therapy, rehabilitation, and clinician education.

Digital phenotyping and real-time sensing:

Use of smartphones and wearables to track mental health patterns.

Data ethics, privacy, and responsible AI use:

Protecting patient rights while leveraging digital health solutions.

AI-based clinical decision support:

Artificial intelligence tools assisting diagnosis and treatment planning.

Scaling digital therapeutics and mobile interventions:

Strategies for implementing validated digital tools globally.

Participation Benefits

All participants of FutureMind 2027 will gain benefits that go beyond attendance. The congress is designed to ensure knowledge-sharing, professional growth, and recognition. Benefits include:

Full access to keynotes, sessions, workshops, and the Innovation Forum.
Certificate of Participation (with CME/CE credits if applicable).
Eligibility for research awards and recognition.
Opportunities to present work in oral, poster, or e-poster formats.
High-value networking with peers, industry experts, and global leaders.
Exclusive exposure to publishing opportunities and professional collaborations.

Submission Guidelines

Abstracts for oral, poster, or e-poster presentations should not exceed 300 words, structured into Background, Methods, Results, and Conclusion. Include 8–10 keywords and clearly identify the presenting author. Posters should be a maximum of 1m x 1m. Submissions will be peer-reviewed on novelty, scientific quality, and clinical impact.

Key Dates:

Abstract Submission Opens: 15 March 2027

Early Submission Deadline: 15 February 2027

Final Submission Deadline: 15 Jan 2027

Notification of Acceptance: After 24hrs Abstract Submission

Presenter Registration Deadline: 15 Feb 2027

Venue

About Dubai, UAE

Dubai, UAE, is a leading global hub for business, healthcare, innovation, tourism, and international events. With its modern infrastructure, multicultural environment, and world-class facilities, Dubai provides an ideal setting for an international congress on neuroscience, psychiatry, psychology, and mental health innovation.

The city is easily accessible through Dubai International Airport (DXB) and offers excellent conference venues, hotels, healthcare facilities, and convenient transportation through the Dubai Metro, buses, taxis, and trams.

In March, Dubai experiences warm weather, while its world-class indoor facilities ensure a comfortable experience for international visitors. Delegates can explore iconic attractions such as the Burj Khalifa, Museum of the Future, Palm Jumeirah, Dubai Marina, and Dubai Mall.

With its global outlook, excellent connectivity, and diverse cultural environment, Dubai offers an inspiring destination for networking, collaboration, knowledge exchange, and scientific engagement.

Hosting FutureMind 2027 in Dubai will combine a high-impact academic program with the unique experience of one of the world's most dynamic international cities.

Market Analysis

The global mental health sector is undergoing unprecedented growth, driven by heightened awareness, technological innovation, and the increasing prioritization of mental well-being as a public health imperative. By 2030, the market is projected to surpass USD 400 billion, reflecting a paradigm shift toward integrated, accessible, and personalized mental health care. The industry’s expansion is propelled by major advancements across pharmaceuticals, biotechnology, and digital health ecosystems. Pharmaceutical and biotech companies are developing next-generation therapeutics, including precision psychiatry solutions and long-acting formulations that improve adherence and outcomes. Meanwhile, technology firms are transforming care delivery through AI-powered diagnostics, telepsychiatry platforms, and wearable-based mental health monitoring tools, bridging the gap between patients and providers worldwide.

Policy initiatives are also accelerating growth, as governments and international organizations embed mental health services within primary care systems, emphasizing prevention, accessibility, and equity. The academic and research communities are contributing through innovations in neuroscience, psychosomatic medicine, and translational research, driving new insights into brain–body interactions. This convergence of clinical expertise, technological innovation, and evidence-based policymaking is reshaping the global mental health landscape—creating a more collaborative, data-driven, and patient-centered model poised to define the next decade of healthcare transformation.

FutureMind 2027 positions itself as a catalyst in this market evolution by providing a collaborative platform that empowers professionals, supports innovation, and aligns academia with industry and policy. The congress aims to accelerate solutions that not only advance science but also make mental health care more accessible, equitable, and effective